MSCs promotes tumour growth by increasing the number of cancer stem cells through bone morphogenetic protein signalling and WNT, TGF‐β, IL‐6/JAK2/STAT3 signalling pathways.66 This evidence concerns the gene STAT3 and neoplasm.